Skip to main content
SpringerLink
Log in

Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary?

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Herbal medicinal products have to meet comparable standards concerning the assessment of efficacy, safety and (bio)pharmaceutical quality as chemically defined synthetic drugs. However, these requirements are not fulfilled for many herbal products so far, particularly regarding in vitro dissolution and in vivo bioavailability.

The necessity of in vivo studies for a biopharmaceutical characterisation of the products depends on the solubility/permeability properties of the active drug ingredient as well as dissolution behaviour of the dosage form. Also, in the case of herbal medicinal products, a waiver of in vivo BA/BE studies is recommended as long as the active ingredient is highly soluble according to the Biopharmaceutics Classification System and dissolution of the dosage form takes place rapidly (>85%/20 min) in physiological buffer systems (pH 1–8).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Blume H., Ali S.L., Siewert M. (1984): Zur pharmazeutischen Qualität von glibenclamidhaltigen Fertigarzneimitteln. Pharm. Ztg., 129, 983–989.

    CAS  Google Scholar 

  2. Blume H., Ali S.L., Stenzhorn G., Stüber W., Siewert M. (1985): Zur Bioverfügbarkeit und pharmakodynamischen Aktivität handelsüblicher Glibenclamid-Fertig-arzneimittel., 3. Mitt. Bioäquivalenzprüfung an gesunden Probanden unter Dauerinfusion von Glucoselösung. Pharm. Ztg., 130, 2605–2610.

    CAS  Google Scholar 

  3. Steinigen M. (1984): Vergleichende Untersuchung zur Qualität indometacinhaltiger Fertigarzneimittel. Pharm. Ztg., 129, 2578–2582.

    Google Scholar 

  4. Blume H., Stüber W., Stenzhorn G., Sörgel F. (1988): Untersuchungen zur Bioverfügbarkeit von Indometacin-Retardzubereitungen, 1. Mitt.: Ergebnisse einer Single-dose-Studie. Pharm. Ztg. Wiss., 1/133, 12–20.

    Google Scholar 

  5. Amidon G.L., Lennernäs H., Shah V.P., Crison J.R. (1995): A theoretical basis for a biopharmaceutic drug classification: the correlation ofin vitro drug product dissolution andin vivo bioavailability. Pharm. Res., 12, 413–420.

    Article  CAS  PubMed  Google Scholar 

  6. Knutson L., Odlind B., Hallgren R. (1989): A new technique for segmental perfusion in man. Am. J. Gastroenterol., 84, 1278–1284.

    CAS  PubMed  Google Scholar 

  7. Hidalgo J.J., Raub T.J., Borchardt R.T. (1989): Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749.

    CAS  PubMed  Google Scholar 

  8. CPMP Note for Guidance on specifications: test procedure and acceptance criteria for herbal drug preparations (herbal drugs) and herbal medicinal products (EMEA/HMPWG/19/99 draft), 28 January 1999.

  9. Tittel G. (1997): Qualitätskontrolle von Phytopharmaka. Pharm. Ind., 59, 1002–1012.

    CAS  Google Scholar 

  10. SocraTec internal report BP-02.ba, 1999.

  11. Schulz H-U., Schürer M., Krumbiegel G., Wächter W., Weyhenmeyer R., Seidel G. (1995): Untersuchungen zum Freisetzungsverhalten und zur Bioäquivalenz von Silymarin-Präparaten. Arzneimittelforsch., 45, 61–64.

    CAS  PubMed  Google Scholar 

  12. Staffeldt B., Kerb R., Brockmöller J., Ploch M., Roots I. (1994): Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers., J. Geriatr. Psychiatry Neurol., 47–53.

  13. Biber A., Fischer H., Römer A., Chatterjee S.S. (1998): Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Pharmacopsychiatry, 31, 36–43.

    Article  CAS  PubMed  Google Scholar 

  14. Brockmöller J., Reum T., Bauer S., Kerb R., Hübner W-H., Roots I. (1997): Hypericin and pseudohypericin — pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry, 30, S94-S101.

    Article  Google Scholar 

  15. Blume H. (1998): Bioverfügbarkeitsstudien bei Phytopharmaka: Alptraum oder Notwendigkeit? Vortrag DPhG Symposium zur Qualität von Phytopharmaka, 2–4 April 1998, Bad Homburg.

  16. Ammon H.P.T. (1998): Diskussionsbemerkung DPhG Symposium zur Qualität von Phytopharmaka, 2–4 April 1998, Bad Homburg.

  17. Müller W.E., Singer A., Wonnemann M., Hafner U., Rolli M., Schäfer C. (1998): Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract. Pharmacopsychiatry, 31, 16–21.

    Article  PubMed  Google Scholar 

  18. Ammon H.P.T., Mack T., Singh G.B., Safayhi H. (1991): Inhibition of leukotrien B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata. Planta Med., 57, 203–207.

    Article  CAS  PubMed  Google Scholar 

  19. Kunkel H. (1993): EEG profile of three different extractions of Ginkgo biloba. Neuropsychobiology, 27, 40–45.

    Article  CAS  PubMed  Google Scholar 

  20. FDA Guidance for Industry. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Containing Certain Active Moieties/Active Ingredients Based on a Biopharmaceutics Classification System. (CDERGUID/2062DFT.WPD Draft January 1999).

  21. Blume H., Schug B. (1999) Class III drugs — better candidates for BA/BE waiver? Eur. J. Pharm. Sci., In press.

  22. Polli J.E. (1997):In vitro-in vivo relationship of several ‘immediate’ release tablets containing a low permeability drug. Adv. Exp. Med. Biol. 423, 191–198.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SocraTec R & D, Feldbergstraße 59, D-61440, Oberursel, Germany

    H. H. Blume & B. S. Schug

Authors
  1. H. H. Blume
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. S. Schug
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blume, H.H., Schug, B.S. Biopharmaceutical characterisation of herbal medicinal products: are in vivo studies necessary?. Eur. J. Drug Metab. Pharmacokinet. 25, 41–48 (2000). https://doi.org/10.1007/BF03190057

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03190057

Keywords

Search

Navigation